US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Galileo Mining Limited (GAL) 銘柄情報

Galileo Mining Limited (GAL)

0.115

0.005

(4.55%)

終了 7月4日 3:00PM

Galileo Mining Limited (GAL) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.115

( 4.55% )

買値

0.11

売値

0.125

出来高

4,211

0.115 日の範囲 0.12

0.10 52 週間の範囲 0.31

時価総額

前日終値

0.11

始値

0.115

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 204,788

発行済株式数

197,624,927

配当利回り

PER

-34.3

1 株当たり利益 (EPS)

-0

歳入

-

純利益

-649.92k

Galileo Mining Ltd engages in the exploration of mineral deposits in Western Australia. The company explores for palladium, platinum, rhodium, cobalt, nickel, lithium, and copper deposits. It holds 100% interest in the Norseman project that covers an area of 278 square kilometers located to the town... Galileo Mining Ltd engages in the exploration of mineral deposits in Western Australia. The company explores for palladium, platinum, rhodium, cobalt, nickel, lithium, and copper deposits. It holds 100% interest in the Norseman project that covers an area of 278 square kilometers located to the town of Norseman; and 67% interest Fraser Range Project covering an area of 602 square kilometers located in the Albany-Fraser Orogen. Galileo Mining Ltd was incorporated in 2003 and is based in West Perth, Australia. 詳細を表示

セクター

Materials

業界

Mining

ウェブサイト

www.galileomining.com.au

本社

West Perth, Australia

設立

2026

Galileo Mining Limited is listed in the Materials sector of the オーストラリア証券取引所 with ticker GAL. The last closing price for Galileo Mining was AUD0.11. Over the last year, Galileo Mining shares have traded in a share price range of AUD 0.10 to AUD 0.31.

Galileo Mining currently has 197,624,927 shares in issue. The market capitalisation of Galileo Mining is AUD22.73 million. Galileo Mining has a price to earnings ratio (PE ratio) of -34.30.

Notice of Results

RNS Number:5078U Galen Holdings PLC 21 January 2004 Galen Holdings plc Q1 Results Date Craigavon, Northern Ireland, UK / Rockaway, New...

Exclusivity Period for Ovcon

RNS Number:3641U Galen Holdings PLC 19 January 2004 GALEN HOLDINGS PLC GALEN ANNOUNCES EXCLUSIVITY PERIOD FOR OVCON Craigavon...

Annual Report and Accounts

RNS Number:7810T Galen Holdings PLC 02 January 2004 Galen Holdings PLC 2 January 2004 Doc Re 2003 Annual Report and Accounts A copy of...

Issue of Patent

RNS Number:6486T Galen Holdings PLC 24 December 2003 GALEN HOLDINGS PLC GALEN ANNOUNCES PATENT FOR CHEWABLE ORAL CONTRACEPTIVES...

FTC Request for Information

RNS Number:6399T Galen Holdings PLC 23 December 2003 Barr Laboratories, Inc. Carol A. Cox Tel: 201-930-3720 email: ccox@barrlabs.com...

Director Shareholding

RNS Number:5312T Galen Holdings PLC 22 December 2003 22 December 2003 GALEN HOLDINGS PLC Directors Shareholding Notification...

Director Shareholding

RNS Number:8856S Galen Holdings PLC 4 December 2003 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1...

Holding(s) in Company

RNS Number:7859S Galen Holdings PLC 2 December 2003 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1) NAME OF COMPANY...

Disposal

RNS Number:7276S Galen Holdings PLC 02 December 2003 2nd December 2003 NOT FOR RELEASE OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA...

Regulatory Approval

RNS Number:1238S Galen Holdings PLC 17 November 2003 GALEN HOLDINGS PLC NEW OVCON(R) 35 RECEIVES FDA APPROVAL Craigavon...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.01	9.52380952381	0.105	0.12	0.1	324960	0.10345502	DE
4	-0.005	-4.16666666667	0.12	0.14	0.1	261840	0.11563888	DE
12	-0.045	-28.125	0.16	0.165	0.1	213308	0.13168801	DE
26	-0.065	-36.1111111111	0.18	0.31	0.1	408143	0.21114827	DE
52	0	0	0.115	0.31	0.1	338739	0.200828	DE
156	-0.46	-80	0.575	0.68	0.1	242672	0.22902911	DE
260	-0.16	-58.1818181818	0.275	1.95	0.1	634299	0.80231037	DE

GAL - Frequently Asked Questions (FAQ)

What is the current Galileo Mining Limited share price?

The current share price of Galileo Mining Limited is AUD 0.115

How many Galileo Mining Limited shares are in issue?

Galileo Mining Limited has 197,624,927 shares in issue

What is the market cap of Galileo Mining Limited?

The market capitalisation of Galileo Mining Limited is AUD 22.73M

What is the 1 year trading range for Galileo Mining Limited share price?

Galileo Mining Limited has traded in the range of AUD 0.10 to AUD 0.31 during the past year

What is the PE ratio of Galileo Mining Limited?

The price to earnings ratio of Galileo Mining Limited is -34.3

What is the registered address of Galileo Mining Limited?

The registered address for Galileo Mining Limited is 945 Wellington Street, West Perth, Western Australia, 6005

What is the Galileo Mining Limited website address?

The website address for Galileo Mining Limited is www.galileomining.com.au

Which industry sector does Galileo Mining Limited operate in?

Galileo Mining Limited operates in the Mining sector

Doc logic

Doc logic 1分前

SkyLimit2022,

Combo effect has been known by big pharma since 2014 based on their own research. They just don’t want their checkpoint inhibitors moving into second place vs DCVax-L. Best wishes.

Troubles1

Troubles1 2分前

I’ll try to find out the capacity of that compressor station. I’ll see if I can find one of the Williams technicians this week and see if they know anything. I’ll be right next-door to their compressor sub in Starks Louisiana this next week. We start our pig run on Tuesday

surfkast

surfkast 3分前

So they paid $700,000 for a worthless license. Got it! Hopium reigns!

Thomas@yahoo

Thomas@yahoo 3分前

💥🍿 Breaking News:Further expansion of our subsidiary culturedfoods.eu and PlusHLTH

💥🍿 https://allegro.pl/listing?string=cultured%20foods 🤑

💥🍿 https://allegro.pl/listing?string=plushlth. 🤑

&#

PEMBROKE1

PEMBROKE1 4分前

Sounds good to me.

Non filing is why the YEILD sign is there.

monkeybusiness

monkeybusiness 6分前

Mask the codes and do third-party testing on the tech!

Lone Clone

Lone Clone 9分前

Oreterra Geological Staff Mobilize to Trek South Copper-Gold Prospect, Golden Triangle, BC, to Prepare for Maiden Drill Program

https://www.newsfilecorp.com/release/303897/Oreterra-Geological-Staff-Mobilize-to-Trek-South-CopperGold-Prospect-Golden-Triangle-BC-to-Prepare-for-Maiden-Dr

Doc logic

Doc logic 11分前

Idunno,

BP’s last hope is their influence on US patent office decisions. Once the combo comes through they are cooked; ). Best wishes.

Hey_Its_That_Guy

Hey_Its_That_Guy 11分前

We at least you have an uplisted by now

BigMoneyChalupa

BigMoneyChalupa 12分前

I still question why the convertible note holders are not aggressively dumping their millions of $$$'s in convertible bonds into the bid. Legitimate question and not being sarcastic at all. I mean it is crazy to me how they have all these convertible loans and an available bid to dump into, and yet

Vexari

Vexari 13分前

How so
Nope. That is inappropriate.. Not looking good for dr. Falsi hey boys! Watch him rat out a bit on bourlap dog. What's behind the curtain

manibiotech

manibiotech 14分前

Not sure how do you reach at 6-9 months conclusion . You do realize that 9 months is 270 days which would be more than long enough for new application submission without any clock off periods . I strongly disagree with your conclusion unless you can give any precedence/any other example or the facts

indepth05

indepth05 14分前

We need to stop the conspiracy framing and deal with the actual, observable mechanics and historical facts, because that is what reality is built on in markets like this.
Lehman’s reported ~$600B balance sheet was never a pool of liquid, realisable capital. It was a gross accounting structure

SkyLimit2022

SkyLimit2022 14分前

The reference to the https://clinicaltrials.gov/study/NCT04201873 combo with Hiltonol & Keytruda was particularly noteworthy along with the specific
https://www.nature.com/articles/s41467-024-48073-y Nature Comms citation. NCT04201873 has an estimated primary completion date of Aug 1

kfa670

kfa670 14分前

Maybe a stupid question but...

With this data now in hand, would it make sense to go after an FDA approval in conjunction with MHRA?

Lone Clone

Lone Clone 15分前

Blast Resources Announces Exploration Results at Its Flagship Wales Lake Project in the Athabasca Basin Region, Saskatchewan

https://www.newsfilecorp.com/release/303832/Blast-Resources-Announces-Exploration-Results-at-Its-Flagship-Wales-Lake-Project-in-the-Athabasca-Basin-Region-Saska

Forensics888

Forensics888 15分前

Could be, but when one is in a situation like this and Trump has already acknowledged the atrocity of this in his letter regarding socialism - it would be best for them to come out as heroes and end this, instead of victims of a court ruling.

This is Trump's mantra - America first, Am

boston745

boston745 18分前

Here again media is publishing articles with misinformation in its headlines. Before there were several articles indicating Autopilot used used meanwhile the body of the article would say self driving. Now The Guardian is claiming Tesla said that Mr. Butler disengaged FSD when he supposedly applied

boston745

boston745 19分前

Here again media is publishing articles with misinformation in its headlines. Before there were several articles indicating Autopilot used used meanwhile the body of the article would say self driving. Now The Guardian is claiming Tesla said that Mr. Butler disengaged FSD when he supposedly applied

reg2015

reg2015 20分前

Does any one knoe what NWBO closed at today in London? Thank you. Peace Reg2015

attilathehunt

attilathehunt 20分前

You said…"and in my view the MHRA's review of it will take at least 6 to 9 months. So if NWBO submitted it around March, we're realistically looking at another 4 to 7 months of waiting from here before a decision."

What if they submitted the data in December? Then only one month….

Zadie420

Zadie420 20分前

The question is did NWBO prided this finding to MHRA for further consideration, If yes, then when.....

flipper44

flipper44 21分前

I think it’s for a NICE evidence submission. My guess is MHRA already reviewed it, and perhaps they even helped, regardless, NWBO needs to be transparent about the process.

beartrap12

beartrap12 22分前

On multiple looks, it appears this chart on page 6 is the original survival figures used in JAMA. If so, the PSM analysis doubles that delta (distance between the treated group and the PSM matches). It's hard to tell without Dr. Bosch's words explaining what you're looking at in these slides. But Bo

Driver Australia Eleven

VanEck Morningstar US ES...

UBS MSCI Pacific ex Japa...

Inari Amertron Berhad (PK)

Franklin Future of Healt...

ETFMG Real Estate Tech ETF

Copper Mountain Mining

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。